Is a personalized pharmacotherapeutic approach closed for acute coronary syndrome?

MLA

Amit Rout, et al. “Is a Personalized Pharmacotherapeutic Approach Closed for Acute Coronary Syndrome?” Expert Opinion on Pharmacotherapy, vol. 22, Jan. 2021, pp. 527–29. EBSCOhost, https://doi.org/10.1080/14656566.2021.1877659.

APA

Amit Rout, Kevin P. Bliden, Paul A. Gurbel, & Udaya S. Tantry. (2021). Is a personalized pharmacotherapeutic approach closed for acute coronary syndrome? Expert Opinion on Pharmacotherapy, 22, 527–529. https://doi.org/10.1080/14656566.2021.1877659

Chicago

Amit Rout, Kevin P. Bliden, Paul A. Gurbel, and Udaya S. Tantry. 2021. “Is a Personalized Pharmacotherapeutic Approach Closed for Acute Coronary Syndrome?” Expert Opinion on Pharmacotherapy 22 (January): 527–29. doi:10.1080/14656566.2021.1877659.